Advanced search
Publication Cover
Research and Reports in Urology Volume 14, 2022 - Issue
Submit an article Journal homepage
342
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs

Fabio Turco1 IOSI (Oncology Institute of Southern Switzerland), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland;2 Department of Oncology, University of Turin, at Division of Medical Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, 10043, ItalyCorrespondence[email protected]
View further author information
,
Silke Gillessen1 IOSI (Oncology Institute of Southern Switzerland), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland;3 Universita della Svizzera Italiana, Lugano, SwitzerlandView further author information
,
Richard Cathomas4 Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, SwitzerlandView further author information
,
Consuelo Buttigliero2 Department of Oncology, University of Turin, at Division of Medical Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, 10043, ItalyORCID Iconhttps://orcid.org/0000-0002-2877-2518View further author information
ORCID Icon &
Ursula Maria Vogl1 IOSI (Oncology Institute of Southern Switzerland), Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-3111-7888View further author information
ORCID Icon
Pages 339-350 | Received 10 Jul 2022, Accepted 14 Sep 2022, Published online: 29 Sep 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andrea Marchetti, Elisa Tassinari, Matteo Rosellini, Alessandro Rizzo, Francesco Massari & Veronica Mollica. (2023) Prostate cancer and novel pharmacological treatment options–what’s new for 2022?. Expert Review of Clinical Pharmacology 16:3, pages 231-244.
Read now

Articles from other publishers (4)

Shuyi Zhou, Xixi Hou, Ling Li, LiHao Guo, Huili Wang, Longfei Mao, Leilei Shi & Miaomiao Yuan. (2023) Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage. Bioorganic Chemistry 141, pages 106926.
Crossref
Zheng Qin, Dongze Liu, Yueyao Zhang, Xiaoxu Chen, Xiao Zhu, Shengxian Xu, Baolong Peng, Shiqiang Dong, Dingkun Hou, Liang Zhu & Haitao Wang. (2023) Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo . Oncologie 25:6, pages 717-728.
Crossref
Ruiying Qiu, Ke Bu, Hengqing An & Ning Tao. (2023) A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model. PeerJ 11, pages e16158.
Crossref
Diana V. Maslov, Quinne Sember, Jason Cham & Munveer Bhangoo. (2023) A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer. Frontiers in Oncology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.